| Literature DB >> 33841843 |
Uthaiwan Suttisansanee1,2, Pornsiri Pitchakarn3, Pisamai Ting1, Woorawee Inthachat1,2, Parunya Thiyajai1, Daraphan Rodthayoy3, Jirarat Karinchai3, Bhanumas Chanatarasuwan4, Onanong Nuchuchua5, Piya Temviriyanukul1,2.
Abstract
Ficus species have been used as a typical component in food and folk medicine in Asia for centuries. However, little is known regarding the bioactivity and genotoxicity of the recently identified Ficus dubia (FD), an indigenous plant of the tropical evergreen rain forest. FD is unique from other Ficus species because of its highly sought-after red-brown latex. Antioxidant properties together with phenolic and flavonoid contents of FD were elucidated. Health-promoting characteristics were examined by studying the inhibition of enzymes as a drug target for diabetes, hypertension, Alzheimer's disease, and obesity, together with anticancer ability against human colorectal adenocarcinoma, human hepatocellular carcinoma, human ovarian carcinoma, human prostate adenocarcinoma, and human lung carcinoma. Besides, FD genotoxicity was tested using the Drosophila wing spot test. Results showed that both FD root and latex exhibited antioxidant activity due to the presence of phenolics and flavonoids, specifically caffeic acid and cyanidin. The ethanolic fraction of FD root demonstrated a potent antidiabetic mechanism underlying α-glucosidase inhibitory activity similar to acarbose. This fraction also suppressed lung and ovarian cancer growth, possibly by G1 and G2/M arrest, respectively. All tested fractions lacked mutagenicity in vivo. Results indicated that FD can be developed as novel antidiabetic compounds; however, its bioactive compounds should be further identified.Entities:
Keywords: Drosophila melanogaster; Ficus dubia; Ficus species; antidiabetes; antioxidant; cancer
Year: 2021 PMID: 33841843 PMCID: PMC8020917 DOI: 10.1002/fsn3.2205
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Antioxidant activities of RW30, RW80, REt30, and latex
| Sample |
ABTS radical scavenging activity SC50 value (µg/ml) |
DPPH radical scavenging activity SC50 value (µg/ml) | FRAP (µmol TE/g extract) | ORAC (µmol TE/g extract) |
|---|---|---|---|---|
| RW30 | 56.51 ± 2.24B | 611.30 ± 36.92A | 515 ± 37.90C | 1,678 ± 94D |
| RW80 | 38.76 ± 3.26D | 460.55 ± 18.08C | 601 ± 21.10B | 2,059 ± 107C |
| REt30 | 43.39 ± 0.38C | 250.31 ± 102.66D | 830 ± 22.75A | 2,671 ± 85B |
| Latex | 87.09 ± 0.89A | 579.67 ± 15.03B | 461 ± 34.67D | 7,976 ± 70A |
| Catechin | 2.04 ± 0.03E | 4.42 ± 0.06E | ND | ND |
Data are presented as mean ± SD of triplicate determinations. Capital letter within a column for a given parameter is significantly different from each other at p <.05. The statistical package for social sciences (SPSS) was used to calculate for statistical difference by one‐way analysis of variance (ANOVA) and Duncan's multiple comparison test.
Abbreviation: ND, not determined.
Total phenolic contents (TPCs) and total flavonoid contents (TFCs) of RW30, RW80, REt30, and latex
| Sample | Total phenolic contents (mg GAE/g extract) | Total flavonoid contents (mg QE/g extract) |
|---|---|---|
| RW30 | 137.85 ± 5.75C | 319.12 ± 17.16B |
| RW80 | 133.71 ± 1.11C | 269.78 ± 16.68C |
| REt30 | 249.20 ± 3.72B | 359.87 ± 5.79A |
| Latex | 311.01 ± 13.34A | 88.93 ± 6.52D |
Data are presented as mean ± SD of triplicate experiments. Capital letter within a column for a given parameter is significantly different from each other at p <.05. The SPSS program was used to calculate for statistical difference by one‐way analysis of variance (ANOVA) and Duncan's multiple comparison test.
Phenolic acid and flavonoid identification of RW30, RW80, REt30, and latex after acid hydrolysis by HPLC compared with authentic standards
| Sample | Phenolic acid: Caffeic acid (µg/100 g extract) | Flavonoid: Cyanidin (µg/100 g extract) |
|---|---|---|
| RW30 | 272.90 ± 0.97D | 7.49 ± 2.97C |
| RW80 | 1,452.14 ± 26.51C | 94.03 ± 13.39B |
| REt30 | 2,720.86 ± 186.03A | 449.39 ± 17.45A |
| Latex | 1,559.85 ± 15.10B | ND |
Data are presented as mean ± SD of triplicate experiments. Capital letter within a column for a given parameter are significantly different from each other at p <.05. The SPSS program was used to calculate for statistical difference by one‐way analysis of variance (ANOVA) and Duncan's multiple comparison test.
ND, not detected.
The IC50 values and percent inhibition of RW30, RW80, REt30, and latex against α‐glucosidase, AChE, ACE and lipase
| Sample | IC50 (µg/ml) | % Inhibition | ||
|---|---|---|---|---|
| α‐Glucosidase | AChE | ACE | Lipase | |
| RW30 | 303.05 ± 15.20A | 115.65 ± 6.15D | 100.81 ± 7.34C | 12.02 ± 0.57C |
| RW80 | 137.95 ± 16.19B | 874.30 ± 32.81A | 152.60 ± 8.06B | 20.61 ± 1.29B |
| REt30 | 97.92 ± 8.03C | 452.80 ± 36.49B | 53.70 ± 2.40D | ND |
| Latex | ND | 376.50 ± 18.24C | 315.20 ± 3.96A | 39.87 ± 2.87A |
Data are presented as mean ± SD of triplicate experiments. Capital letter within a column for a given parameter are significantly different from each other at p <.05. The SPSS program was used to calculate for statistical difference by one‐way analysis of variance (ANOVA) and Duncan's multiple comparison test.
Abbreviation: ND, not detected.
Final concentration of FD extracts in antilipase assay was 400 µg/ml.
FIGURE 1Effect of REt30 and latex on cell viability of human colorectal adenocarcinoma (SW620), human hepatocellular carcinoma (HepG2), human ovarian carcinoma (SKOV‐3), human prostate adenocarcinoma (PC3), and human lung carcinoma (A549). Data are expressed as mean ± standard deviation (SD) of three experiments. The percentage of cell viability of each cell line (% cell viability) was calculated, and statistical significance of each cell line was analyzed by Student's unpaired t test against its control group. *p <.05; **p <.01; ***p <.001; and ****p <.0001
The half inhibitory concentration (IC50) values and the selectivity index (SI) of REt30 against five cancer cell lines
| Cancer cell lines | REt30 | |
|---|---|---|
| IC50 (µg/ml) | Selectivity Index | |
| SW620 | >500 | ND |
| HepG2 | 337 ± 39 | >2.4 |
| A549 | 268 ± 46 | >3.0 |
| PC3 | 350 ± 11 | >2.3 |
| SKOV3 | 323 ± 15 | >2.5 |
| Normal cells (3T3‐L1) | >800 | ND |
Data are presented as mean ± SD of triplicate experiments. The SI index was calculated as the IC50 ratio of REt30 on 3T3‐L1 to each cancer cell line at the same duration time of treatment.
Abbreviation: ND, not determined.
FIGURE 3Cell cycle progression of A549 cells treated with REt30 or cisplatin for 48 hr. (a) Untreated, (b) 300 µg/ml of REt30, (c) 400 µg/ml of REt30, (d) 500 µg/ml of REt30, (e) 14 µM of cisplatin, (f) percentage of cells in G1 phase, (g) percentage of cells in S phase, and (h) percentage of cells in G2/M phase. Values are presented as mean ± SD of three independent experiments. *p <.05 and ***p <.001 vs. control
FIGURE 4Survival percentage of adult flies obtained from trans‐heterozygous mwh+/+flr 3 larvae with improved high bioactivation cross‐fed on standard medium (NDM) and experimental medium containing 20 mM urethane or RW30, RW80, REt30, and latex (0.25, 1, and 2 mg/ml)
Summary of somatic mutation and recombination test data obtained from trans‐heterozygous flies after exposure to RW30, RW80, REt30, or latex at 2 mg/ml
| Treatment | Spots/wing (number of spots from 40 wings) | |||
|---|---|---|---|---|
| Sample | Small single ( | Large single ( | Twin spot ( | Total spot ( |
| Negative control | 0.48 (19) | 0.05 (2) | 0 (0) | 0.53 (21) |
| Urethane, 20mM | 15.53 (621)+ | 7.03 (281)+ | 2.08 (83)+ | 24.63 (985)+ |
| RW30 (1st experiment) | 0.30 (12)− | 0 (0)i | 0.03 (1)i | 0.33 (13)− |
| RW30 (2nd experiment | 0.23 (9)− | 0.08 (3)i | 0 (0)i | 0.30 (12)− |
| RW80 (1st experiment) | 0.40 (16)− | 0 (0)i | 0.03 (1)i | 0.43 (17)− |
| RW80 (2nd experiment | 0.08 (3)− | 0.23 (9)+ | 0.08 (3)i | 0.38 (15)i |
| REt30 (1st experiment) | 0.25 (10)− | 0 (0)i | 0 (0)i | 0.25 (10)− |
| REt30 (2nd experiment | 0.25 (10)− | 0.03 (1)i | 0 (0)i | 0.28 (11)− |
| Latex (1st experiment) | 0.28 (11)− | 0 (0)i | 0 (0)i | 0.28 (11)− |
| Latex (2nd experiment | 0.30 (12)− | 0.10 (4)i | 0.03 (1)i | 0.43 (17)i |
Statistical diagnoses using estimation of spot frequencies and confidence limits according to for comparison with deionized water (Frei & Wurgler, 1988) (negative control); + = positive; − = negative; i = inconclusive. Probability levels: α = β = 0.05. One‐sided statistical test “m” is an increased mutation frequency compared with the spontaneous frequency (m times).
Summary of somatic mutation recombination test data and percent inhibition of trans‐heterozygous flies coexposed to 20 mM urethane and RW30, RW80, REt30, and latex at different concentrations
| Treatment | Spots per wing (number of spots from 40 wings) | ||||
|---|---|---|---|---|---|
| Sample | Small single spot ( | Large single spot ( | Twin spot ( | Total spot ( | Inhibition (%) |
| Negative control | 0.95 (38) | 0 (0) | 0.03 (1) | 0.98 (39) | — |
| Urethane (URE), 20mM | 18.95 (758) | 9.50 (380) | 2.15 (86) | 30.60 (1,224) | — |
| RW30 (0.25 mg/ml) + URE | 12.33 (493) | 7.30 (292) | 2.20 (88) | 21.83 (873) | 29 (W) |
| RW30 (1 mg/ml) + URE | 14.40 (576) | 6.10 (244) | 2.0 (80) | 22.5 (900) | 26 (W) |
| RW30 (2 mg/ml) + URE | 12.33 (493) | 6.58 (263) | 1.75 (70) | 20.65 (826) | 33 (W) |
| RW80 (0.25 mg/ml) + URE | 13.48 (539) | 7.35 (294) | 2.28 (91) | 23.1 (924) | 25 (W) |
| RW80 (1 mg/ml) + URE | 15.70 (628) | 5.33 (213) | 1.70 (68) | 22.73 (909) | 26 (W) |
| RW80 (2 mg/ml) + URE | 11.78 (471) | 5.13 (205) | 1.53 (61) | 18.43 (737) | 40 (W) |
| REt30 (0.25 mg/ml) + URE | 18.30 (732) | 8.18 (327) | 2.50 (100) | 28.98 (1,159) | 5 (N) |
| REt30 (1 mg/ml) + URE | 15.75 (630) | 6.65 (266) | 1.70 (68) | 24.10 (964) | 21 (W) |
| REt30 (2 mg/ml) + URE | 16.53 (661) | 9.40 (376) | 2.35 (94) | 28.28 (1,131) | 8 (N) |
| Latex (0.25 mg/ml) + URE | 16.28 (651) | 7.75(310) | 2.33 (93) | 26.55 (1,054) | 14 (N) |
| Latex (1 mg/ml) + URE | 18.70 (748) | 6.90 (276) | 1.90 (76) | 27.50 (1,100) | 10 (N) |
| Latex (2 mg/ml) + URE | 15.35 (614) | 5.68 (227) | 1.40 (56) | 22.43 (897) | 27 (W) |
Percent of inhibition = ((A − B)/A) × 100. Where A is the number of total spots per wing of positive urethane control group, B is the number of total spots per wing of each experimental group. “N” Express as negligible effect and “W” express as weak inhibitory effect of 20 mM urethane.